Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Casebook
  • Published:

Perinatal/Neonatal Case Book

OxyContin and Neonatal Abstinence Syndrome

Abstract

Opioids are a commonly abused class of drugs. OxyContin® abuse, a long-acting oxycodone derivative, has been increasingly identified as a potent narcotic resulting in drug dependence, overdose and even death. Use during pregnancy may result in withdrawal symptoms in the neonate. However, detection of the drug and its metabolites needs special methods in order to initiate appropriate therapy.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Finnegan LP . Neonatal abstinence In: Nelson NM, editor Current Therapy in Neonatal–Perinatal Medicine Toronto, Ontario: BC Decker, Inc 1985 p 262–70

    Google Scholar 

  2. American Academy of Pediatrics Committee on Drugs. Neonatal withdrawal Pediatrics 1998 101: 1079–87

  3. Finnegan LP, Kaltenbach K . Neonatal abstinence syndrome In: Hoekelman RA, Friedman SB, Nelson N, Seidel HM, editors Primary Pediatric Care 2nd ed St. Louis, MO: CV Mosby 1992 p 1367–78

    Google Scholar 

  4. Cheville A, Chen A, Oster G, McGarry L, Narcessian E . A randomized trial of controlled release oxycodone during inpatient rehabilitation following unilateral total knee arthroplasty J Bone Joint Surg Am 2001 83A: 4 572–6

    Article  Google Scholar 

  5. Roth SH, Fleischmann RM, Burch FX et al. Around the clock, controlled release oxycodone therapy for osteoarthritis related pain: placebo controlled trial and long-term evaluation Arch Intern Med 2000 160: 6 853–60

    Article  CAS  Google Scholar 

  6. Citron ML, Kaplan R, Parris WC et al. Long-term administration of controlled release oxycodone tablets for treatment of cancer pain Cancer Invest 1998 16: 8 562–71

    Article  CAS  Google Scholar 

  7. In Murray L, Sifton DW, Reilly S editors. Physician's Desk Reference 55th ed NJ: Medical Economics Co. Inc 2001 p 2697–701

    Google Scholar 

  8. Cohen G . The “poor man's heroin.” An Ohio surgeon helps feed a growing addiction to Oxycontin US News World Rep Feb 12, 2001 130: 6 27

    CAS  PubMed  Google Scholar 

  9. Oxycontin diversion and abuse In National Drug Intelligence Center, Johnstown, PA, USA US Department of Justice Bulletin Information January 2001

  10. Commonwealth of Kentucky Justice Cabinet. Presented at the Kentucky Coroners'/Medical Examiners' Annual Conference, April 2001

  11. Finnegan LP . Management of pregnant drug-dependent women Ann NY Acad Sci 1978 311: 143–6

    Article  Google Scholar 

  12. Fischer G, Johnson RE, Eder H et al. Treatment of opioid dependent pregnant women with buprenorphine Addiction 2000 95: 2 239–44

    Article  CAS  Google Scholar 

  13. CSAT Advisory Oxycontin: Prescription Drug Abuse April 2001 1: 1 1–8

  14. Joranson DE, Ryan KM, Gilson AM, Dahl JL . Trends in medical use and abuse of opioid analgesics JAMA 2000 283: 1710–4

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rao, R., Desai, N. OxyContin and Neonatal Abstinence Syndrome. J Perinatol 22, 324–325 (2002). https://doi.org/10.1038/sj.jp.7210744

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210744

Search

Quick links